Glenmark gets ANDA approval for dimethyl fumarate delayed-release capsules
MUMBAI, India — Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for dimethyl fumarate delayed-release capsules, 120 mg and 240 mg, the generic version of Tecfidera1 Delayed-Release Capsules, 120 mg and 240 mg, of Biogen. According to IQVIATM sales data for the 12 month period ending
